TTY Biopharm Company Limited announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced total revenue was TWD 1,043.174 million compared to TWD 901.099 million a year ago. Operating income was TWD 272.055 million compared to TWD 212.853 million a year ago. Net income was TWD 31.879 million compared to TWD 185.560 million a year ago. Basic earnings per share was TWD 0.13 compared to TWD 0.75 a year ago. For the half year, total revenue was TWD 2,007.230 million compared to TWD 1,994.566 million a year ago. Operating income was TWD 491.217 million compared to TWD 496.594 million a year ago. Net income was TWD 235.023 million compared to TWD 439.131 million a year ago. Basic earnings per share was TWD 0.95 compared to TWD 1.77 a year ago. Diluted earnings per share was TWD 0.94 compared to TWD 1.76 a year ago.